Literature DB >> 9062343

Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease.

Y Terauchi1, K Iwamoto, H Tamemoto, K Komeda, C Ishii, Y Kanazawa, N Asanuma, T Aizawa, Y Akanuma, K Yasuda, T Kodama, K Tobe, Y Yazaki, T Kadowaki.   

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) is considered a polygenic disorder in which insulin resistance and insulin secretory defect are the major etiologic factors. Homozygous mice with insulin receptor substrate-1 (IRS-1) gene knockout showed normal glucose tolerance associated with insulin resistance and compensatory hyperinsulinemia. Heterozygous mice with beta cell glucokinase (GK) gene knockout showed impaired glucose tolerance due to decreased insulin secretion to glucose. To elucidate the interplay between insulin resistance and insulin secretory defect for the development of NIDDM, we generated double knockout mice with disruption of IRS-1 and beta cell GK genes by crossing the mice with each of the single gene knockout. The double knockout mice developed overt diabetes. Blood glucose levels 120 min after intraperitoneal glucose load (1.5 mg/g body wt) were 108 +/- 24 (wild type), 95 +/- 26 (IRS-1 knockout), 159 +/- 68 (GK knockout), and 210 +/- 38 (double knockout) mg/dl (mean +/- SD) (double versus wild type, IRS-1, or GK; P < 0.01). The double knockout mice showed fasting hyperinsulinemia and selective hyperplasia of the beta cells as the IRS-1 knockout mice (fasting insulin levels: 0.38 +/- 0.30 [double knockout], 0.35 +/- 0.27 [IRS-1 knockout] versus 0.25 +/- 0.12 [wild type] ng/ml) (proportion of areas of insulin-positive cells to the pancreas: 1.18 +/- 0.68%; P < 0.01 [double knockout], 1.20 +/- 0.93%; P < 0.05 [IRS-1 knockout] versus 0.54 +/- 0.26% [wild type]), but impaired insulin secretion to glucose (the ratio of increment of insulin to that of glucose during the first 30 min after load: 31 [double knockout] versus 163 [wild type] or 183 [IRS-1 knockout] ng insulin/mg glucose x 10(3)). In conclusion, the genetic abnormalities, each of which is nondiabetogenic by itself, cause overt diabetes if they coexist. This report provides the first genetic reconstitution of NIDDM as a polygenic disorder in mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9062343      PMCID: PMC507893          DOI: 10.1172/JCI119250

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Dual functional role of membrane depolarization/Ca2+ influx in rat pancreatic B-cell.

Authors:  Y Sato; T Aizawa; M Komatsu; N Okada; T Yamada
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

2.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

Authors:  E Araki; M A Lipes; M E Patti; J C Brüning; B Haag; R S Johnson; C R Kahn
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

Review 3.  Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?

Authors:  S I Taylor; D Accili; Y Imai
Journal:  Diabetes       Date:  1994-06       Impact factor: 9.461

4.  Risk factors for worsening to diabetes in subjects with impaired glucose tolerance.

Authors:  T Kadowaki; Y Miyake; R Hagura; Y Akanuma; H Kajinuma; N Kuzuya; F Takaku; K Kosaka
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

5.  Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients.

Authors:  C Johnston; W K Ward; J C Beard; B McKnight; D Porte
Journal:  Diabet Med       Date:  1990-02       Impact factor: 4.359

6.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

Authors:  B C Martin; J H Warram; A S Krolewski; R N Bergman; J S Soeldner; C R Kahn
Journal:  Lancet       Date:  1992-10-17       Impact factor: 79.321

7.  ATP-sensitive K+ channel-independent glucose action in rat pancreatic beta-cell.

Authors:  T Aizawa; Y Sato; F Ishihara; N Taguchi; M Komatsu; N Suzuki; K Hashizume; T Yamada
Journal:  Am J Physiol       Date:  1994-03

8.  Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat.

Authors:  D Gauguier; P Froguel; V Parent; C Bernard; M T Bihoreau; B Portha; M R James; L Penicaud; M Lathrop; A Ktorza
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

9.  Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain.

Authors:  K Kawano; T Hirashima; S Mori; Y Saitoh; M Kurosumi; T Natori
Journal:  Diabetes       Date:  1992-11       Impact factor: 9.461

10.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.

Authors:  S Lillioja; D M Mott; M Spraul; R Ferraro; J E Foley; E Ravussin; W C Knowler; P H Bennett; C Bogardus
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  33 in total

Review 1.  The genetics of type 2 diabetes.

Authors:  M McCarthy; S Menzel
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

Review 2.  Insights into insulin resistance and type 2 diabetes from knockout mouse models.

Authors:  T Kadowaki
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 3.  New insights into the integrated physiology of insulin action.

Authors:  Yukari Kitamura; Domenico Accili
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

4.  Development of novel cell lines of diabetic dysfunction model fit for cell-based screening tests of medicinal materials.

Authors:  Mikako Saito; Aya Hayakawa; Nobuya Inagaki; Hideaki Matsuoka
Journal:  Cytotechnology       Date:  2012-07-10       Impact factor: 2.058

5.  Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.

Authors:  Yasuo Terauchi; Iseki Takamoto; Naoto Kubota; Junji Matsui; Ryo Suzuki; Kajuro Komeda; Akemi Hara; Yukiyasu Toyoda; Ichitomo Miwa; Shinichi Aizawa; Shuichi Tsutsumi; Yoshiharu Tsubamoto; Shinji Hashimoto; Kazuhiro Eto; Akinobu Nakamura; Mitsuhiko Noda; Kazuyuki Tobe; Hiroyuki Aburatani; Ryozo Nagai; Takashi Kadowaki
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

6.  MG53-mediated cell membrane repair protects against acute kidney injury.

Authors:  Pu Duann; Haichang Li; Peihui Lin; Tao Tan; Zhen Wang; Ken Chen; Xinyu Zhou; Kristyn Gumpper; Hua Zhu; Thomas Ludwig; Peter J Mohler; Brad Rovin; William T Abraham; Chunyu Zeng; Jianjie Ma
Journal:  Sci Transl Med       Date:  2015-03-18       Impact factor: 17.956

Review 7.  Hyperinsulinism and diabetes: genetic dissection of beta cell metabolism-excitation coupling in mice.

Authors:  Maria Sara Remedi; Colin G Nichols
Journal:  Cell Metab       Date:  2009-12       Impact factor: 27.287

8.  Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus.

Authors:  Naoto Kubota; Yasuo Terauchi; Kazuyuki Tobe; Wataru Yano; Ryo Suzuki; Kohjiro Ueki; Iseki Takamoto; Hidemi Satoh; Toshiyuki Maki; Tetsuya Kubota; Masao Moroi; Miki Okada-Iwabu; Osamu Ezaki; Ryozo Nagai; Yoichi Ueta; Takashi Kadowaki; Tetsuo Noda
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

9.  IRS2 takes center stage in the development of type 2 diabetes.

Authors:  Matthew J Brady
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Fulminant type 1 diabetes mellitus observed in insulin receptor substrate 2 deficient mice.

Authors:  T Arai; H Hashimoto; K Kawai; A Mori; Y Ohnishi; K Hioki; M Ito; M Saito; Y Ueyama; M Ohsugi; R Suzuki; N Kubota; T Yamauchi; K Tobe; T Kadowaki; K Kosaka
Journal:  Clin Exp Med       Date:  2008-07-11       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.